Literature DB >> 29241672

Catatonia with schizophrenia: From ECT to rTMS.

E Stip1, M-E Blain-Juste2, O Farmer3, M-P Fournier-Gosselin4, P Lespérance5.   

Abstract

BACKGROUND: Electroconvulsive therapy is indicated in cases of catatonic schizophrenia following a failure of the challenge test with lorazepam or Zolpidem®. Some patients need maintenance treatment with ECT. Repetitive Transcranial Magnetic Stimulation (rTMS) and anodal Transcranial direct-current stimulation (tDCS) might be effective against catatonia.
OBJECTIVE: Consider an alternative to ECT for a refractory patient. REVIEW: Twenty-one articles were identified mainly based on case reports series were found using search on Medline, Google Scholar, PsychInfo, CAIRNS. Key words were:"catatonia", and "rTMS", and more generally with"ECT","tDCS","Zolpidem®". At the end there were only six case reports with rTMS and three with tDCS. We discussed the alternative to ECT and follow up rTMS strategies illustrated by these case reports.
FINDINGS: Patients mean age was 35; numbers of previous ECT vary from zero to 556; the most common motor threshold (MT) is 80%, with two patients with 110%, the most common treatment placement is L DLPFC. In one of them, ECT was the only acute-state or maintenance treatment effective in this patient, who underwent 556 ECT sessions over 20 years. High-frequency rTMS was considered as a possible alternative, given the potential adverse effects of chronic maintenance ECT in a patient with comorbid epilepsy. rTMS treatment was 3-4×/week and over time extended to once every two weeks. A persistent objective improvement in catatonia was observed on the Bush-Francis Catatonia Rating Scale.
CONCLUSION: rTMS is helpful for acute and maintenance treatment for catatonic schizophrenia who both failed multiple pharmacologic interventions and had safety concerns with continuing maintenance ECT. Clinicians should consider rTMS as a potential treatment option for refractory catatonia.
Copyright © 2017 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Brain stimulation; Catatonia; Catatonie; Electroconvulsivotherapy; Schizophrenia; Schizophrénie; Stimulation magnétique transcraienne; Zolpidem(®); rTMS

Mesh:

Year:  2017        PMID: 29241672     DOI: 10.1016/j.encep.2017.09.008

Source DB:  PubMed          Journal:  Encephale        ISSN: 0013-7006            Impact factor:   1.291


  4 in total

Review 1.  Association of the Thrombo-embolic Phenomenon with Electroconvulsive Therapy Treatment in Schizophrenia with Catatonia Patient.

Authors:  Zain I Warriach; Sohaib A Shamim; Aisha Saeed; Saima Kashif; Bilal Haider Malik
Journal:  Cureus       Date:  2019-09-14

2.  Efficacy and safety of repetitive transcranial magnetic stimulation for generalised anxiety disorder: A meta-analysis.

Authors:  Huiru Cui; Lijuan Jiang; Yanyan Wei; Wei Li; Hui Li; Junjuan Zhu; Jiaoyan Pang; Jijun Wang; Chunbo Li
Journal:  Gen Psychiatr       Date:  2019-09-24

3.  Use of repetitive transcranial magnetic stimulation in the treatment of catatonia.

Authors:  Christiane Licht; Axel Ruttmann; Thomas Hillemacher; Kneginja Richter
Journal:  J Psychiatry Neurosci       Date:  2022-07-12       Impact factor: 5.699

Review 4.  Paralyzed by Fear?-A Case Report in the Context of Narrative Review on Catatonia.

Authors:  Karina Badura Brzoza; Patryk Główczyński; Michał Błachut
Journal:  Int J Environ Res Public Health       Date:  2022-08-16       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.